Rosalia Viterbo, MD, FACS

Dr. Viterbo
​​
This physician is not currently rated. Why?

Why is this doctor not rated?

Close

To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings
Request an Appointment

Clinical Locations

Associate Professor, Department of Urology

Treatment Focus

Robotic surgery and adrenal carcinoma

Key Awards

2023 top doctors
Urology

Treatment Philosophy

Coming from a large family, I believe in an approach to cancer care that involves the individual and the family. Personally, I treat my patients the way I would want my family treated—with honesty, compassion and skill.

Joining Fox Chase Cancer Center is the realization of a personal lifelong goal. The Center brings together the perspectives of innovative physicians and researchers to deliver revolutionary and cutting-edge treatment options to everyone. This tradition fits with my longtime dedication to provide patients with the best medical and surgical care.

I came to Fox Chase from City of Hope National Medical Center where I completed my fellowship in a leading robotic oncology program. Having had experience with more than 1,500 robotic prostatectomies, partial nephrectomy, cystectomy and neobladder, indiana pouch and ileal conduit diversions, I have treated patients with various urologic malignancies. I did this through the use of robotics and minimally invasive surgery, as well as open surgery, when appropriate. At Fox Chase, my goal is to continue offering excellent care and leading edge technology, ultimately to benefit the individual outcome and overall quality of life of my patients.

With today's advancing technology, it is critical for me, as a surgeon, to keep current with the expanding base of knowledge and make contributions that translate into reducing the burden of cancer. This starts with the individual and then applies to populations. This knowledge will be invaluable throughout my career as I care for my patients, make decisions, assume leadership responsibilities and respond to complex situations.

Follow on Twitter: @FCUroOnc

Educational Background

  • Fellow, Robotic Urologic Oncology, City of Hope National Medical Center, Duarte, CA
  • Resident, General Surgery and Urology, Temple University Hospital, Philadelphia, PA
  • MD, State University of New York at Buffalo School of Medicine and Biomedical Sciences, 2000

Certifications

  • American Board of Urology

Memberships

  • Society of Urologic Oncology
  • American Urological Association
  • Philadelphia Urological Society
  • American College of Surgeons
Pete Serratore

Pete Serratore

  • Prostate Cancer

Believe it or not, my prostate cancer journey started with a tingly toe.

I turned 69 in October 2020, and soon after, my right big toe started tingling. I thought it could be an early sign of arthritis—I did martial arts when I was younger, which I figured could be the cause—so I went to see my doctor.

VIEW PATIENT STORY

Joe Kline

  • Kidney Cancer

My journey with kidney cancer actually started when I fell in my driveway and injured my eye. I had to go to the hospital for treatment, and they gave me anesthesia before stitching up the eye. After they sent me home, I had trouble urinating.

The doctors said it was probably a side effect of the anesthesia. But a couple of days later, when I had to go back to the hospital for a follow-up procedure, it hadn’t gotten better. By then, my bladder was so full I felt like I would explode.

VIEW PATIENT STORY

Research Interests

  • Prostate cancer
  • Robotic and minimally invasive surgery, including prostatectomy, nephrectomy and cystectomy with neobladder and indiana pouch diversion
  • Robotic salvage prostatectomy
  • Prostate, kidney, bladder and testicular cancer

Selected Publications

Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol, 199(5):1238-44, 2018. PubMed

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...
​​